Dr. Boyd, a cancer researcher and genomics expert, also was appointed a professor and member of the Cold Spring Harbor Laboratory Cancer Center.
In his new position, he will develop a molecular diagnostics laboratory for the Northwell’s cancer institute as well as focus on academic relationships with the health system’s scientific collaborators, Northwell said in a news release.
Dr. Boyd most recently was associate deputy director, translational research and genomic medicine, at the Miami Cancer Institute at Baptist Health South Florida. He also served as professor and chair of the department of human and molecular genetics, professor of obstetrics and gynecology and associate dean for basic research and graduate programs at Florida International University’s Herbert Wertheim College of Medicine in Miami.
He currently serves on the Society of Gynecologic Oncology board of directors.
More articles on executive moves:
Douwe Bergsma named chief marketing officer of Piedmont Healthcare
Ascension names new senior VP, Michigan market executive
Jennifer DeCubellis named Hennepin Healthcare CEO
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
